VCEL - Vericel nabs North American rights to MediWound's NexoBrid May, 07 2019 08:42 AM Vericel Corporation MediWound (NASDAQ:MDWD) has out-licensed exclusive rights to debridement agent NexoBrid to Vericel (NASDAQ:VCEL) in North America.More news on: MediWound Ltd., Vericel Corporation, Healthcare stocks news, Stocks on the move, Read more ...